VITT, COVID-19 and the Expert Haematology Panel: The story of how the UK responded to emerging cases of vaccine-induced immune thrombocytopenia and thrombosis during the vaccination programme-Reference-Cited by-同舟云学术

VITT, COVID-19 and the Expert Haematology Panel: The story of how the UK responded to emerging cases of vaccine-induced immune thrombocytopenia and thrombosis during the vaccination programme

Published:2021-10-13 Issue:6 Volume:21 Page:e600-e602
ISSN:1470-2118
Container-title:Clinical Medicine
language:en
Short-container-title:Clin Med

Author:

Chevassut Tim,Hunt Beverley J,Pavord Sue

Publisher

Royal College of Physicians

Subject

General Medicine

Reference8 articles.

1. SARS-CoV-2 vaccine-induced immune thrombotic thrombocytopenia;Cines;N Engl J Med,2021

2. Evaluation of laboratory assays for anti‐platelet factor 4 antibodies after ChAdOx1 nCOV‐19 vaccination

3. Thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination;Schultz;N Engl J Med,2021

4. Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination

5. Pathologic Antibodies to Platelet Factor 4 after ChAdOx1 nCoV-19 Vaccination

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Thrombosis with thrombocytopenia syndrome (TTS) and vaccine-induced immune thrombocytopenia and thrombosis (VITT): Brighton Collaboration case definitions and guidelines for data collection, analysis, and presentation of immunisation safety data;Vaccine;2024-03

2. Case report: Successful thromboprophylaxis with enoxaparin in a pregnant woman with internal jugular vein agenesis;Frontiers in Medicine;2022-11-22

3. Impact of COVID-19 on the liver and on the care of patients with chronic liver disease, hepatobiliary cancer, and liver transplantation: An updated EASL position paper;Journal of Hepatology;2022-10

4. Successful Treatment of SARS-CoV-2 Vaccination-related Activation of Rheumatoid Arthritis with Positive Findings for Epstein-Barr Virus;Internal Medicine;2022-07-01

5. Comparative analysis of ChAdOx1 nCoV-19 and Ad26.COV2.S SARS-CoV-2 vector vaccines;Haematologica;2022-01-20